WallStreetZenWallStreetZen

NASDAQ: DMAC
Diamedica Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Diamedica Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DMAC annual revenue was $0.0, with N/A growth year-over-year.

DMAC revenue history

Current Revenue
$0.0
Current Earnings
-$24.4M
Current Profit Margin
0%

Be the first to know when DMAC announces revenue.

DMAC Revenue History By Year

DMAC Yearly RevenueDMAC RevenueDMAC ChangeDMAC Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00-$500.00k-100.00%
2018-12-31$500.00kN/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Diamedica Therapeutics Revenue FAQ

What was DMAC's revenue last quarter?

On Invalid Date, Diamedica Therapeutics (NASDAQ: DMAC) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Diamedica Therapeutics's revenue was $0.00.

What was Diamedica Therapeutics's revenue in 2024?

Diamedica Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Diamedica Therapeutics make in a day?

Based on Diamedica Therapeutics annual revenue for the past five years, DMAC makes an average of $0.00 per day.

What was Diamedica Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Diamedica Therapeutics's revenue has grown null year over year. Diamedica Therapeutics's revenue in the past year totaled $0.00.

How much does Diamedica Therapeutics make in a year?

Diamedica Therapeutics's revenue by year for the past five years is:
  • Diamedica Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Diamedica Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Diamedica Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Diamedica Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Diamedica Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.